EVERSANA has taken another step forwards in its effort to put generative artificial intelligence (GenAI) at the heart of the pharma industry’s processes.
Understanding the needs and behaviour of healthcare professionals is the number one priority for pharma as it interacts with the medical profession in 2024, marking a grad
Eversana has acquired pharmaphorum parent Healthware Group in a move that elevates the longstanding partnership between the companies, expands their geographic reach, and
Stefan Woxström leads the Europe and Canada business at AstraZeneca and brings a wealth of experience from 27 years with the organisation, having held a variety of local and regional roles
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.